Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment

Kevin Robertson; Alan Landay; Sachiko Miyahara; Alyssa Vecchio; Mary Clare Masters; Todd T. Brown; Babafemi O. Taiwo

doi:10.1007/s13365-019-00795-2

Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment

Kevin Robertson, Alan Landay, Sachiko Miyahara, Alyssa Vecchio, Mary Clare Masters, Todd T. Brown, Babafemi O. Taiwo

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

The AIDS Clinical Trials Group (ACTG) study A5303 investigated the associations between neuropsychological performance (NP) and inflammatory biomarkers in HIV-infected participants. Fifteen NP tests were administered at baseline and week 48 to 233 ART naïve participants randomized to maraviroc- or tenofovir-containing ART. Neurocognition correlated modestly with markers of lymphocyte activation and inflammation pre-ART (percent CD38+/HLA-DR+(CD4+) (r = − 0.22, p = 0.02) and percent CD38+/HLA-DR+(CD8+) (r = − 0.25, p = 0.02)), and with some monocyte subsets during ART (r = 0.25, p = 0.02). Higher interleukin-6 and percent CD38+/HLA-DR+(CD8+) were independently associated with worse severity of HIV-associated neurocognitive disorders (HAND) (p = 0.04 and 0.01, respectively). More studies to identify HAND biomarkers are needed.

Original language	English (US)
Pages (from-to)	107-113
Number of pages	7
Journal	Journal of neurovirology
Volume	26
Issue number	1
DOIs	https://doi.org/10.1007/s13365-019-00795-2
State	Published - Feb 1 2020
Externally published	Yes

Keywords

Antiretroviral therapy
Biomarker
Inflammation
Monocytes
Neurocognitive performance

ASJC Scopus subject areas

Neurology
Clinical Neurology
Cellular and Molecular Neuroscience
Virology

Access to Document

10.1007/s13365-019-00795-2

Cite this

@article{6aba0539f4c74222b29304fcd5a53f17,

title = "Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment",

abstract = "The AIDS Clinical Trials Group (ACTG) study A5303 investigated the associations between neuropsychological performance (NP) and inflammatory biomarkers in HIV-infected participants. Fifteen NP tests were administered at baseline and week 48 to 233 ART na{\"i}ve participants randomized to maraviroc- or tenofovir-containing ART. Neurocognition correlated modestly with markers of lymphocyte activation and inflammation pre-ART (percent CD38+/HLA-DR+(CD4+) (r = − 0.22, p = 0.02) and percent CD38+/HLA-DR+(CD8+) (r = − 0.25, p = 0.02)), and with some monocyte subsets during ART (r = 0.25, p = 0.02). Higher interleukin-6 and percent CD38+/HLA-DR+(CD8+) were independently associated with worse severity of HIV-associated neurocognitive disorders (HAND) (p = 0.04 and 0.01, respectively). More studies to identify HAND biomarkers are needed.",

keywords = "Antiretroviral therapy, Biomarker, Inflammation, Monocytes, Neurocognitive performance",

author = "Kevin Robertson and Alan Landay and Sachiko Miyahara and Alyssa Vecchio and Masters, {Mary Clare} and Brown, {Todd T.} and Taiwo, {Babafemi O.}",

note = "Publisher Copyright: {\textcopyright} 2019, Journal of NeuroVirology, Inc.",

year = "2020",

month = feb,

day = "1",

doi = "10.1007/s13365-019-00795-2",

language = "English (US)",

volume = "26",

pages = "107--113",

journal = "Journal of neurovirology",

issn = "1355-0284",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment

AU - Robertson, Kevin

AU - Landay, Alan

AU - Miyahara, Sachiko

AU - Vecchio, Alyssa

AU - Masters, Mary Clare

AU - Brown, Todd T.

AU - Taiwo, Babafemi O.

PY - 2020/2/1

Y1 - 2020/2/1

N2 - The AIDS Clinical Trials Group (ACTG) study A5303 investigated the associations between neuropsychological performance (NP) and inflammatory biomarkers in HIV-infected participants. Fifteen NP tests were administered at baseline and week 48 to 233 ART naïve participants randomized to maraviroc- or tenofovir-containing ART. Neurocognition correlated modestly with markers of lymphocyte activation and inflammation pre-ART (percent CD38+/HLA-DR+(CD4+) (r = − 0.22, p = 0.02) and percent CD38+/HLA-DR+(CD8+) (r = − 0.25, p = 0.02)), and with some monocyte subsets during ART (r = 0.25, p = 0.02). Higher interleukin-6 and percent CD38+/HLA-DR+(CD8+) were independently associated with worse severity of HIV-associated neurocognitive disorders (HAND) (p = 0.04 and 0.01, respectively). More studies to identify HAND biomarkers are needed.

AB - The AIDS Clinical Trials Group (ACTG) study A5303 investigated the associations between neuropsychological performance (NP) and inflammatory biomarkers in HIV-infected participants. Fifteen NP tests were administered at baseline and week 48 to 233 ART naïve participants randomized to maraviroc- or tenofovir-containing ART. Neurocognition correlated modestly with markers of lymphocyte activation and inflammation pre-ART (percent CD38+/HLA-DR+(CD4+) (r = − 0.22, p = 0.02) and percent CD38+/HLA-DR+(CD8+) (r = − 0.25, p = 0.02)), and with some monocyte subsets during ART (r = 0.25, p = 0.02). Higher interleukin-6 and percent CD38+/HLA-DR+(CD8+) were independently associated with worse severity of HIV-associated neurocognitive disorders (HAND) (p = 0.04 and 0.01, respectively). More studies to identify HAND biomarkers are needed.

KW - Antiretroviral therapy

KW - Biomarker

KW - Inflammation

KW - Monocytes

KW - Neurocognitive performance

UR - http://www.scopus.com/inward/record.url?scp=85072052448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072052448&partnerID=8YFLogxK

U2 - 10.1007/s13365-019-00795-2

DO - 10.1007/s13365-019-00795-2

M3 - Article

C2 - 31468473

AN - SCOPUS:85072052448

SN - 1355-0284

VL - 26

SP - 107

EP - 113

JO - Journal of neurovirology

JF - Journal of neurovirology

IS - 1

ER -

Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this